Korean J Dermatol.  2002 Apr;40(4):341-347.

Antifungal Susceptibility Testing in Three-dimensional Keratinocyte Culture Model

Affiliations
  • 1Department of Dermatology, Seoul National University College of Medicine, Seoul, Korea. jakim@snu.ac.kr
  • 2Department of Dermatology, Sungkyunkwan University School of Medicine, Seoul, Korea.

Abstract

BACKGROUND: Standardization of antifungal susceptibility testing for dermatophytes is important and several variables, such as inoculum size, length and temperature of incubation, media, and end point determination has recently been established. However, a more improved test model which can evaluate bioavailability and has clinical relevance is still needed.
OBJECTIVE
We performed antifungal susceptibility testing by using three-dimensional keratinoctyte culture model, living skin equivalent (LSE), as an in vitro model.
METHODS
LSE was prepared and various concentrations of antifungals were added to media. Microconidia of Trichophyton mentagrophytes was inoculated onto LSE and incubated for 6 days at 35 degrees C.
RESULTS
Inhibition of fungal proliferation and invasion were observed at 0.1microgram/ml of terbinafine, 0.01 microgram/ml of itraconazole solution, 0.1 microgramg/ml of itraconazole powder, and 10 microgram/ml of fluconazole, respectively.
CONCLUSION
Our culture model is similar to in vivo situation and the results were relatively well accordant to those of other previous studies. Our LSE model is considered as a promising in vitro system for evaluating the activity and safety of antifungal agents. However, further study using more various species of dermatophytes and more strains is still needed.

Keyword

Antifungal susceptibility; Dermatophyte; Keratinocyte culture

MeSH Terms

Antifungal Agents
Arthrodermataceae
Biological Availability
Endpoint Determination
Fluconazole
Itraconazole
Keratinocytes*
Skin
Trichophyton
Antifungal Agents
Fluconazole
Itraconazole
Full Text Links
  • KJD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr